DCM
DGS Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-429
| Closed | -$451K | – | 326 |
|
|
2024
Q3 | $451K | Buy |
429
+52
| +14% | +$54.7K | 0.12% | 167 |
|
|
2024
Q2 | $396K | Buy |
377
+1
| +0.3% | +$1.05K | 0.11% | 169 |
|
|
2024
Q1 | $362K | Hold |
376
| – | – | 0.1% | 179 |
|
|
2023
Q4 | $330K | Sell |
376
-1
| -0.3% | -$878 | 0.13% | 151 |
|
|
2023
Q3 | $310K | Sell |
377
-12
| -3% | -$9.88K | 0.15% | 146 |
|
|
2023
Q2 | $280K | Sell |
389
-16
| -4% | -$11.5K | 0.14% | 160 |
|
|
2023
Q1 | $333K | Sell |
405
-17
| -4% | -$14K | 0.19% | 130 |
|
|
2022
Q4 | $304K | Sell |
422
-76
| -15% | -$54.8K | 0.2% | 131 |
|
|
2022
Q3 | $343K | Buy |
498
+4
| +0.8% | +$2.76K | 0.23% | 99 |
|
|
2022
Q2 | $292K | Buy |
494
+71
| +17% | +$42K | 0.24% | 109 |
|
|
2022
Q1 | $295K | Sell |
423
-35
| -8% | -$24.4K | 0.18% | 118 |
|
|
2021
Q4 | $289K | Buy |
+458
| New | +$289K | 0.18% | 99 |
|